Elk Creek Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $17.9M | Buy |
|
|||||
|
2019
Q4 | $24.7M | Sell |
|
|||||
|
2019
Q3 | $34M | Buy |
|
|||||
|
2019
Q2 | $27.5M | Buy |
|
|||||
|
2019
Q1 | $26.4M | Buy |
|
|||||
|
2018
Q4 | $12.5M | Buy |
|
|||||
|
2018
Q3 | $17.4M | Sell |
|
|||||
|
2018
Q2 | $17.6M | Sell |
|
|||||
|
2018
Q1 | $16.8M | Sell |
|
|||||
|
2017
Q4 | $18.4M | Buy |
|
|||||
|
2017
Q3 | $17.8M | Sell |
|
|||||
|
2017
Q2 | $16.2M | Sell |
|
|||||
|
2017
Q1 | $15.6M | Buy |
|
|||||
|
2016
Q4 | $11.6M | Sell |
|
|||||
|
2016
Q3 | $12.7M | Buy |
|